Musa, N., Okasha, A., Allam, A., Halima, A. (2021). The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients. test, 85(1), 3313-3318. doi: 10.21608/ejhm.2021.197377
Nevine Ibrahim Musa; Amr Ahmed Okasha; Ahmed Samir Allam; Ahmed Samir abo Halima. "The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients". test, 85, 1, 2021, 3313-3318. doi: 10.21608/ejhm.2021.197377
Musa, N., Okasha, A., Allam, A., Halima, A. (2021). 'The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients', test, 85(1), pp. 3313-3318. doi: 10.21608/ejhm.2021.197377
Musa, N., Okasha, A., Allam, A., Halima, A. The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients. test, 2021; 85(1): 3313-3318. doi: 10.21608/ejhm.2021.197377